Dr Cloudius Sagandira
AfOx Visiting Research Fellow
Dr Cloudius Ray Sagandira is a Principal Researcher at the Council for Scientific and Industrial Research in South Africa and an AfOx Visiting Researcher at the University of Oxford.
He holds a PhD in Chemistry from Nelson Mandela University and has received advanced training across leading academic and industrial institutions, including Chimie ParisTech, the University of Basel, Novartis, and DiverChim. His research focuses on applying enabling technologies such as continuous flow chemistry and data driven optimisation to develop scalable, cost effective, and sustainable manufacturing processes for chemicals and medicines. His work is driven by a commitment to building resilient pharmaceutical and chemical production systems in low-and middle-income countries and improving access to essential medicines. At the University of Oxford, his current research centres on integrating hydrogen driven hydrogenase biocatalytic systems into continuous flow platforms to enable highly selective and sustainable chemical manufacturing.
Dr Sagandira’s research focuses on advancing sustainable pharmaceutical and chemical manufacturing through enabling technologies such as continuous flow chemistry, biocatalysis, and data driven optimisation. His work integrates modern manufacturing approaches with chemical synthesis and biocatalysis to develop efficient, scalable, and sustainable processes for producing medicines and fine chemicals. He is particularly interested in translating these innovations into resilient manufacturing solutions that strengthen local production capacity and expand access to essential medicines in low-and middle-income countries.
Sagandira CR et al. “Synthesis of Prilocaine Hydrochloride in Continuous Flow Systems”, ACS Omega 2025, 10, 35, 40020–40031.
Sagandira CR, “Agile local manufacturing of active pharmaceutical ingredients in Africa could improve health security and economic growth” Comm Med, 5, 358 2025
Sagandira, CR and Len, C, “Microwave-assisted continuous flow synthesis of propofol”. Sustainable Chemistry and Pharmacy, 2024, 42, 101793.
Sagandira, CR et al. “Continuous Flow Manufacturing of Active Pharmaceutical Ingredients in Africa: A Perspective” React. Chem. Eng., 2024,9, 2532-2551.
Sagandira, CR et al. “Rapid multigram scale end-to-end continuous flow synthesis of sulfonylurea anti-diabetes drugs: Gliclazide, chlorpropamide and tolbutamide”, Synthesis, 2021, doi.org/10.1055/a-1664- 2282.
Sagandira, CR et al. “Total synthesis of glipizide and glibenclamide in continuous”, Chemistry – A European Journal, 2021, 27 (64), 16028-16035.
Sagandira, CR et al. “Continuous-Flow Synthesis of (-)-Oseltamivir Phosphate (Tamiflu)”, Synlett, 2020, 31(19), pp. 1925–1929.
Dr Cloudius Sagandira
PhD
- AfOx Visiting Research Fellow